Kim Payne to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Kim Payne has written about Xenograft Model Antitumor Assays.
Connection Strength
0.497
-
Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia. J Investig Med. 2016 Mar; 64(3):740-4.
Score: 0.469
-
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood. 2015 Oct 08; 126(15):1813-22.
Score: 0.028